Trump’s Drug Price Order: Ineffective Gimmick or Real Change?
Trump’s recent executive order calling for broad drug price cuts has sparked a flurry of reactions, ranging from cautious optimism to outright skepticism. The order promises to give drugmakers price targets within the next thirty days, threatening further action if “significant progress” isn’t made within six months. This sounds decisive, yet history suggests a pattern of similar pronouncements followed by inaction.
The timing of this executive order is particularly intriguing. It comes on the heels of the removal of a Biden-era policy that capped insulin prices at $30, a move that effectively raised prices for many patients. Now, the same administration is presenting this new initiative as a solution, creating a sense of déjà vu for those who remember similar, ultimately fruitless, attempts during Trump’s first term.… Continue reading
Matt Underwood